Alphabet Inc’s Beam Therapeutics BEAM Stock Holding History

Alphabet Inc’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11M	Hold	321,604	–	–	0.01%	20
2026 Q1	$7.66M	Hold	321,604	–	–	0.19%	19
2025 Q4	$8.91M	Hold	321,604	–	–	0.35%	18
2025 Q3	$7.81M	Hold	321,604	–	–	0.32%	20
2025 Q2	$5.47M	Hold	321,604	–	–	0.26%	18
2025 Q1	$6.28M	Hold	321,604	–	–	0.4%	17
2024 Q4	$7.98M	Hold	321,604	–	–	0.46%	14
2024 Q3	$7.88M	Hold	321,604	–	–	0.43%	18
2024 Q2	$7.54M	Hold	321,604	–	–	0.38%	18
2024 Q1	$10.6M	Hold	321,604	–	–	0.42%	16
2023 Q4	$8.75M	Hold	321,604	–	–	0.41%	18
2023 Q3	$7.73M	Hold	321,604	–	–	0.5%	19
2023 Q2	$10.3M	Hold	321,604	–	–	0.55%	18
2023 Q1	$9.85M	Hold	321,604	–	–	0.55%	23
2022 Q4	$12.6M	Hold	321,604	–	–	0.73%	20
2022 Q3	$15.3M	Hold	321,604	–	–	0.78%	21
2022 Q2	$12.4M	Hold	321,604	–	–	0.68%	22
2022 Q1	$18.4M	Hold	321,604	–	–	0.6%	23
2021 Q4	$25.6M	Hold	321,604	–	–	0.62%	22
2021 Q3	$28M	Sell	321,604 -313,982	-49%	-$31.5M	0.66%	17
2021 Q2	$81.8M	Sell	635,586 -5,206	-0.8%	-$415K	1.67%	9
2021 Q1	$51.3M	Sell	640,792 -22,899	-3%	-$2.18M	2.07%	11
2020 Q4	$54.2M	Hold	663,691	–	–	2.6%	10
2020 Q3	$16.3M	Hold	663,691	–	–	0.77%	10
2020 Q2	$18.6M	Hold	663,691	–	–	0.86%	10
2020 Q1	$11.9M	Buy	+663,691	New	+$14.4M	0.78%	11

Other funds holding BEAM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CGH

Contrarius Group Holdings Hamilton, Bermuda $2.17B AUM 134.87% 1-Year Est. Return

Alphabet Inc's BEAM Position: Q2 2026 in Review

Alphabet Inc held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 321,604 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #20.

Alphabet Inc first reported a position in BEAM in Q1 2020 and has held it in 26 quarters since. The position peaked at $81.8M in Q2 2021. 195 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Alphabet Inc held 321,604 shares of Beam Therapeutics worth $11M as of Q2 2026.
Alphabet Inc left its Beam Therapeutics share count unchanged in Q2 2026.
Beam Therapeutics made up 0.01% of Alphabet Inc's portfolio in Q2 2026, its #20 holding.
Alphabet Inc first reported a position in Beam Therapeutics in Q1 2020 and has held it in 26 quarters since.
Alphabet Inc's Beam Therapeutics position peaked at $81.8M in Q2 2021.
195 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Alphabet Inc's 13F filing for Q2 2026, filed 7 Aug 2026.